Investment Service Centre
 

Company/Securities Profile
Code:    Company Name:  
Info Type:  
 
Recent Announcements
Related Stocks

 

 
AMGEN-T (4332 )
Company/Securities Name: Amgen Inc.
Principal Activities: Develops, manufactures and markets human therapeutic products used in the areas of neurobiology, hematology, infectious disease and inflamations to fight infection and stimulate the production of blood cells. 
Chairman: Gordon M Binder 
Principal Office: 1840 Dehavilland Drive
Thousand Oaks CA 91320-1789 
Place Incorporated: USA  
Listing Category: Trading Only  
Listing Date : N/A 
Trading Currency: HKD 
Authorised Shares: N/A  
Issued Shares:
(Click here for important notes)
729,675,000 
(as at 2/10/2017)  
Par Value: N/A  
Board Lot: 10 
Market Capitalisation: N/A  
Financial Data (Extracted from Company's Final Results)
Financial Year End Date: 31/12/2007 
Net Asset Value: N/A 
Net Profit (Loss): USD 3,166,000,000 
Earnings per Share: N/A 
Last Updated: 17/10/2017  
   
 

Remarks : Due to reporting and updating time-lag, users should exercise caution when using the data presented in the Investment Service Centre.

* Industry Classification (HSIC) is provided by Hang Seng Indexes Company Limited. Please see the Disclaimer and the Important Notes.

 
Entitlement
Date Announced Ex-date Details Financial year end B/C date Payment date*
No Record
  * Payment date may be indicative only.

Entitlement information is extracted from issuer announcements published on the HKEXnews website. There may be updating time-lag. For latest updates, please click here to view recent announcements.